Moonlake Immunotherapeutics (MLTX) SEC Filings — 2024
18 SEC filings for Moonlake Immunotherapeutics (MLTX) in 2024.
Filings
- MoonLake Immunotherapeutics Appoints New Officers and Directors — 8-K · Dec 18, 2024
- Moonlake Immunotherapeutics SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- MoonLake Immunotherapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- BVF Partners L.P. Amends MoonLake Immunotherapeutics Stake — SC 13D/A · Oct 8, 2024
- MoonLake to Acquire Remaining 49% of Subsidiary — 8-K · Sep 11, 2024
- MoonLake Immunotherapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- MoonLake Immunotherapeutics Files 8-K — 8-K · Jun 10, 2024
- MoonLake Immunotherapeutics Files 8-K on Shareholder Vote — 8-K · Jun 6, 2024
- MoonLake Immunotherapeutics Files 10-K/A Amendment — 10-K/A · May 7, 2024
- MoonLake Immunotherapeutics Announces 2024 Annual General Meeting of Shareholders — DEF 14A · Apr 24, 2024
- MoonLake Immunotherapeutics Closes $100M Public Offering — 8-K · Mar 11, 2024
- BVF Partners L.P. Ups Stake in MoonLake Immunotherapeutics — SC 13D/A · Mar 5, 2024
- MoonLake Immunotherapeutics Files 2023 Annual Report — 10-K · Feb 29, 2024
- MoonLake Immunotherapeutics Files 8-K on Feb 26 — 8-K · Feb 26, 2024
- Moonlake Immunotherapeutics SC 13G/A Filing — SC 13G/A · Feb 15, 2024
- Moonlake Immunotherapeutics SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Moonlake Immunotherapeutics SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- FMR LLC Discloses 6.419% Stake in MoonLake Immunotherapeutics — SC 13G · Feb 9, 2024